SPY423.31+0.20 0.05%
DIA339.40-0.05 -0.01%
IXIC14,276.24+22.98 0.16%

Intersect ENT Posts Narrower Adjusted Loss on Higher Revenue in Q1; Raises FY21 Revenue Outlook

05/10/2021 05:39

09:23 AM EDT, 05/10/2021 (MT Newswires) -- Intersect ENT (XENT) reported Monday an adjusted Q1 loss of $0.51 per diluted share, narrower than a loss of $0.54 a year earlier. Analysts polled by Capital IQ forecast a loss of $0.43.

Revenue for the quarter climbed to $24.3 million from $19.8 million a year ago. Analysts polled by Capital IQ forecast $23.5 million.

The medical device company raised its full-year 2021 revenue outlook to between $117 million to $121 million from the prior $116 million to $120 million range.

Price: 21.04, Change: 0.00, Percent Change: 0.00